Original Study| Volume 23, ISSUE 2, P143-154, February 2023

Circ_0001777 Affects Triple-negative Breast Cancer Progression Through the miR-95-3p/AKAP12 Axis

Published:November 19, 2022DOI:



      Triple Negative Breast Cancer (TNBC) is 1 of the most serious cancer. Circular RNA_0001777 (circ_0001777) expression was decreased in TNBC tissues. However, the molecular mechanism of circ_0001777 remains unknown.


      The expression of circ_0001777, microRNA-95-3p (miR-95-3p) and A-kinase anchor protein 12 (AKAP12) were detected by quantitative real-time fluorescence polymerase chain reaction (qRT-PCR). A series of in vitro experiments were designed to explore the function of circ_0001777 in TNBC cells and the regulatory mechanism between circ_0001777 and miR-95-3p and AKAP12 in TNBC cells. Western blot examined the relative protein levels in TNBC cells. Bioinformatics prediction site predicted the relationship between miR-95-3p and circ_0001777 or AKAP12 and was verified by Dual-luciferase reporter assays. The xenotransplantation model was established to study the role of circ_0001777 in vivo.


      The expression of circ_0001777 and AKAP12 was decreased in TNBC tissues, while the expression of miR-95-3p was increased. Circ_0001777 can sponge miR-95-3p, and AKAP12 is the target of miR-95-3p. In vitro complement experiments, overexpression of circ_0001777 significantly decreased the malignant behavior of TNBC, while co-transfection of miR-95-3p partially up-regulated this change. In addition, AKAP12 knockdown increased the proliferation, migration, and invasion of TNBC cells inhibited by overexpression of circ_0001777. Mechanically, circ_0001777 regulates AKAP12 expression in TNBC cells by sponge miR-95-3p. In addition, in vivo studies have shown that overexpression of circ_0001777 inhibits tumor growth.


      Overexpression of circ_0001777 decreased proliferation, migration, and invasion of TNBC cells by regulating the miR-95-3p/AKAP12 axis, suggesting that circ_0001777/miR-95-3p/AKAP12 axis may be a potential regulatory mechanism for the treatment of TNBC.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Breast Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bray F
        • Ferlay J
        • Soerjomataram I
        • Siegel RL
        • Torre LA
        • Jemal A
        Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
        CA Cancer J Clin. 2018; 68: 394-424
        • Carey L
        • Winer E
        • Viale G
        • Cameron D
        • Gianni L
        Triple-negative breast cancer: disease entity or title of convenience?.
        Nat Rev Clin Oncol. 2010; 7: 683-692
        • Kumar P
        • Aggarwal R.
        An overview of triple-negative breast cancer.
        Arch Gynecol Obstet. 2016; 293: 247-269
        • Shastry M
        • Yardley DA
        Updates in the treatment of basal/triple-negative breast cancer.
        Curr Opin Obstet Gynecol. 2013; 25: 40-48
        • Chen LL
        • Yang L
        Regulation of circRNA biogenesis.
        RNA Biol. 2015; 12: 381-388
        • Liu J
        • Liu T
        • Wang X
        • He A
        Circles reshaping the RNA world: from waste to treasure.
        Mol Cancer. 2017; 16: 58
        • Arnaiz E
        • Sole C
        • Manterola L
        • Iparraguirre L
        • Otaegui D
        • Lawrie CH
        CircRNAs and cancer: biomarkers and master regulators.
        Semin Cancer Biol. 2019; 58: 90-99
        • Zhou Y
        • Ma G
        • Peng S
        • et al.
        Circ_0000520 contributes to triple-negative breast cancer progression through mediating the miR-1296/ZFX axis.
        Thorac Cancer. 2021; 12: 2427-2438
        • Hansen TB
        • Kjems J
        • Damgaard CK
        Circular RNA and miR-7 in cancer.
        Cancer Res. 2013; 73: 5609-5612
        • Salzman J
        • Chen RE
        • Olsen MN
        • Wang PL
        • Brown PO
        Cell-type specific features of circular RNA expression.
        PLoS Genet. 2013; 9e1003777
        • Ye F
        • Gao G
        • Zou Y
        • et al.
        circFBXW7 Inhibits Malignant Progression by Sponging miR-197-3p and Encoding a 185-aa Protein in Triple-Negative Breast Cancer.
        Mol Ther Nucleic Acids. 2019; 18: 88-98
        • Dou D
        • Ren X
        • Han M,
        • et al.
        CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis.
        Cancer Cell Int. 2020; 20: 454
        • Yu J
        • Shen W
        • Xu J
        • Gong B
        • Gao B
        • Zhu J
        circUSP42 Is downregulated in triple-negative breast cancer and associated with poor prognosis.
        Technol Cancer Res Treat. 2020; 191533033820950827
        • Strubberg AM
        • Madison BB.
        MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications.
        Dis Model Mech. 2017; 10: 197-214
        • Han J
        • Yu J
        • Dai Y,
        • et al.
        Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
        Bosn J Basic Med Sci. 2019; 19: 52-59
        • Li Y
        • Zhou Y
        • Mao F
        • et al.
        miR-452 Reverses Abnormal Glycosylation Modification of ERalpha and Estrogen Resistance in TNBC (Triple-Negative Breast Cancer) Through Targeting UGT1A1.
        Front Oncol. 2020; 10: 1509
        • Shen X
        • Lei J
        • Du L
        miR-31-5p may enhance the efficacy of chemotherapy with Taxol and cisplatin in TNBC.
        Exp Ther Med. 2020; 19: 375-383
        • Tao Y
        • Zhao Z
        • Ma J
        • et al.
        MiR-214-3p regulates the viability, invasion, migration and EMT of TNBC cells by targeting ST6GAL1.
        Cytotechnology. 2019; 71: 1155-1165
        • Wang SM
        • Pang J
        • Zhang KJ
        • Zhou ZY
        • Chen FY
        lncRNA MIR503HG inhibits cell proliferation and promotes apoptosis in TNBC cells via the miR-224-5p/HOXA9 axis.
        Mol Ther Oncolytics. 2021; 21: 62-73
        • Turashvili G
        • Lightbody ED
        • Tyryshkin K
        • et al.
        Novel prognostic and predictive microRNA targets for triple-negative breast cancer.
        FASEB J. 2018;
        • Muniategui A
        • Nogales-Cadenas R
        • Vazquez M
        • et al.
        Quantification of miRNA-mRNA interactions.
        PLoS One. 2012; 7: e30766
        • Ding C
        • Yi X
        • Xu J
        • et al.
        Long Non-Coding RNA MEG3 Modifies Cell-Cycle, Migration, Invasion, and Proliferation Through AKAP12 by Sponging miR-29c in Meningioma Cells.
        Front Oncol. 2020; 10537763
        • Parada CA
        • Osbun J
        • Kaur S
        • et al.
        Kinome and phosphoproteome of high-grade meningiomas reveal AKAP12 as a central regulator of aggressiveness and its possible role in progression.
        Sci Rep. 2018; 8: 2098
        • Zhang S
        • Cheng J
        • Quan C
        • et al.
        circCELSR1 (hsa_circ_0063809) contributes to paclitaxel resistance of ovarian cancer cells by regulating FOXR2 expression via miR-1252.
        Mol Ther Nucleic Acids. 2020; 19: 718-730
        • Karreth FA
        • Pandolfi PP
        ceRNA cross-talk in cancer: when ce-bling rivalries go awry.
        Cancer Discov. 2013; 3: 1113-1121
        • He D
        • Yang X
        • Kuang W
        • Huang G
        • Liu X
        • Zhang Y
        The Novel Circular RNA Circ-PGAP3 promotes the proliferation and invasion of triple negative breast cancer by Regulating the miR-330-3p/Myc Axis.
        Onco Targets Ther. 2020; 13: 10149-10159
        • Lai EC
        Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation.
        Nat Genet. 2002; 30: 363-364
        • Soh RYZ
        • Lim JP
        • Samy RP
        • Chua PJ
        • Bay BH
        A-kinase anchor protein 12 (AKAP12) inhibits cell migration in breast cancer.
        Exp Mol Pathol. 2018; 105: 364-370